Latest Methadone Stories
NKTR-181 rates similar to placebo on "drug liking" and "feeling high" scores at all doses studied and differentiates from the widely abused drug oxycodone with high statistical significance (p
The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opiate addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Safe and effective medications to treat opiate addiction are seriously under-utilized, resulting in preventable suffering and death. Washington (PRWEB) June 17, 2013 The American Society of Addiction Medicine (ASAM) will release...
New report shows increasing restrictions on addiction medications WASHINGTON, June 17, 2013 /PRNewswire-USNewswire/ -- The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opioid addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Drug overdoses now kill more Americans than drunk driving car crashes, an epidemic led by misuse of opioid...
Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say may be fueled by misguided concern by patients and their caregivers. Calling the rate of missed doses "unacceptably high," the researchers add that hospitalized patients are at a significantly greater risk of developing venous thromboembolism, or VTE, and that...
Agreement is the first to emerge under exclusive partnership between Imprimis Pharmaceuticals and Professional Compounding Centers of America (PCCA); acquisition allows Imprimis to begin to develop certain innovations created by Ohio-based compounding pharmacy. SAN DIEGO, Calif., June 17, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) today announced it has completed the acquisition of intellectual property (IP) rights related to certain proprietary innovations...
The Patients' Choice Award is based on patient-provided online ratings PLANO, Texas, June 14, 2013 /PRNewswire-USNewswire/ -- Only a small percentage of the nation's physicians are ever honored with a Patients' Choice Award. But Plano Pain Management Dr. Steven Remer belongs to an even more selective group of doctors who are being honored this year as five-time Patients' Choice honorees, marking the award's fifth anniversary. (Photo:...
Oxycodone is mostly used as pain medication, yet it can become habit forming. Recovery Associates’ therapists, counselors and programs help individuals heal from addictive ways. West Palm Beach, FL (PRWEB) June 12, 2013 Oxycodone is a medication that provides relief to individuals suffering from moderate to severe pain symptoms. It has been known to lead people down an addictive path – one that leaves them wanting more medication. Oxycodone is an opioid pain medication, and an opioid...
New findings provide vital step towards exploring pain medications that may lower risks of prescription drug abuse and side effects of painkillers For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often requires patients to take higher doses – increasing risks of harmful side effects and dependency. Now, new research...
NORTH LIBERTY, Iowa, June 11, 2013 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,461,137 to KemPharm for its patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use...
Major Stigma and Anticipated Negative Outcomes Associated With Opioid Dependence Patients and Treatment RICHMOND, Va., June 11, 2013 /PRNewswire/ -- Despite the growing population of individuals living with opioid dependence (addiction) and significant media coverage about this U.S. epidemic, a new national survey reveals both U.S. adults and primary care doctors harbor a variety of misperceptions and stereotypes about opioid dependence that may impact the way the disease - and those...
